Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

ZIMMER BIOMET HOLDINGS ($ZBH) Releases Q4 2025 Earnings

None

ZIMMER BIOMET HOLDINGS ($ZBH) posted quarterly earnings results for Q4 2025 on Tuesday, February 10th. The company reported earnings of $2.42 per share, beating estimates of $2.42 by $0.00. The company also reported revenue of $2,243,800,000, missing estimates of $2,253,364,418 by $-9,564,418.

You can see Quiver Quantitative's $ZBH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ZIMMER BIOMET HOLDINGS Insider Trading Activity

ZBH Insider Trades

ZIMMER BIOMET HOLDINGS insiders have traded $ZBH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:

  • LORI WINKLER (SVP and CHRO) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $309,960.
  • SANG YI (Group President, Asia Pacific) sold 1,200 shares for an estimated $124,301

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ZIMMER BIOMET HOLDINGS Hedge Fund Activity

We have seen 380 institutional investors add shares of ZIMMER BIOMET HOLDINGS stock to their portfolio, and 491 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ZIMMER BIOMET HOLDINGS Government Contracts

We have seen $11,620,778 of award payments to $ZBH over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

ZIMMER BIOMET HOLDINGS Analyst Ratings

Wall Street analysts have issued reports on $ZBH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 01/08/2026
  • RBC Capital issued a "Outperform" rating on 11/06/2025
  • UBS issued a "Sell" rating on 11/06/2025
  • Rothschild & Co issued a "Buy" rating on 09/18/2025

To track analyst ratings and price targets for ZIMMER BIOMET HOLDINGS, check out Quiver Quantitative's $ZBH forecast page.

ZIMMER BIOMET HOLDINGS Price Targets

Multiple analysts have issued price targets for $ZBH recently. We have seen 12 analysts offer price targets for $ZBH in the last 6 months, with a median target of $100.5.

Here are some recent targets:

  • Danielle Antalffy from UBS set a target price of $86.0 on 01/28/2026
  • Lee Hambright from Bernstein set a target price of $99.0 on 01/09/2026
  • Ryan Zimmerman from BTIG set a target price of $112.0 on 01/08/2026
  • Vijay Kumar from Evercore ISI Group set a target price of $120.0 on 01/05/2026
  • Jeff Johnson from Baird set a target price of $100.0 on 12/16/2025
  • Joanne Wuensch from Citigroup set a target price of $94.0 on 12/11/2025
  • Caitlin Roberts from Canaccord Genuity set a target price of $93.0 on 11/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles